Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Diving Hyperb Med ; 47(1): 9-16, 2017 03.
Article in English | MEDLINE | ID: mdl-28357819

ABSTRACT

INTRODUCTION: The aim of this study was to compare two decompression procedures commonly adopted by technical divers: the ZH-L16 algorithm modified by 30/85 gradient factors (compartmental decompression model, CDM) versus the 'ratio decompression strategy' (RDS). The comparison was based on an analysis of changes in diver circulating inflammatory profiles caused by decompression from a single dive. METHODS: Fifty-one technical divers performed a single trimix dive to 50 metres' sea water (msw) for 25 minutes followed by enriched air (EAN50) and oxygen decompression. Twenty-three divers decompressed according to a CDM schedule and 28 divers decompressed according to a RDS schedule. Peripheral blood for detection of inflammatory markers was collected before and 90 min after diving. Venous gas emboli were measured 30 min after diving using 2D echocardiography. Matched groups of 23 recreational divers (dive to 30 msw; 25 min) and 25 swimmers were also enrolled as control groups to assess the effects of decompression from a standard air dive or of exercise alone on the inflammatory profile. RESULTS: Echocardiography at the single 30 min observation post dive showed no significant differences between the two decompression procedures. Divers adopting the RDS showed a worsening of post-dive inflammatory profile compared to the CDM group, with significant increases in circulating chemokines CCL2 (P = 0.001) and CCL5 (P = 0.006) levels. There was no increase in chemokines following the CDM decompression. The air scuba group also showed a statistically significant increase in CCL2 (P < 0.001) and CCL5 (P = 0.003) levels post dive. No cases of decompression sickness occurred. CONCLUSION: The ratio deco strategy did not confer any benefit in terms of bubbles but showed the disadvantage of increased decompression-associated secretion of inflammatory chemokines involved in the development of vascular damage.


Subject(s)
Algorithms , Decompression/methods , Diving/physiology , Inflammation Mediators/blood , Air , Biomarkers/blood , Case-Control Studies , Chemokines/blood , Echocardiography , Embolism, Air/diagnostic imaging , Helium , Humans , Interleukins/blood , Nitrogen , Oxygen , Seawater , Swimming , Time Factors
2.
Mol Nutr Food Res ; 54 Suppl 1: S24-30, 2010 May.
Article in English | MEDLINE | ID: mdl-20077421

ABSTRACT

Controversial data on the lipid-lowering effect of dietary pea proteins have been provided and the mechanisms behind this effect are not completely understood. The aim of the study was to evaluate a possible hypolipidemic activity of a pea protein isolate and to determine whether pea proteins could affect the hepatic lipid metabolism through regulation of genes involved in cholesterol and fatty acid homeostasis. Rats were fed Nath's hypercholesterolemic diets for 28 days, the protein sources being casein or a pea protein isolate from Pisum sativum. After 14 and 28 days of dietary treatment, rats fed pea proteins had markedly lower plasma cholesterol and triglyceride levels than rats fed casein (p<0.05). Pea protein-fed rats displayed higher hepatic mRNA levels of LDL receptor versus those fed casein (p<0.05). Hepatic mRNA concentration of genes involved in fatty acids synthesis, such as fatty acid synthase and stearoyl-CoA desaturase, was lower in pea protein-fed rats than in rats fed casein (p<0.05). In conclusion, the present study demonstrates a marked cholesterol and triglyceride-lowering activity of pea proteins in rats. Moreover, pea proteins appear to affect cellular lipid homeostasis by upregulating genes involved in hepatic cholesterol uptake and by downregulating fatty acid synthesis genes.


Subject(s)
Gene Expression Regulation/drug effects , Hypolipidemic Agents/pharmacology , Lipids/physiology , Pisum sativum , Plant Proteins/pharmacology , Animals , Caseins/pharmacology , Cholesterol/blood , Cholesterol, LDL/blood , DNA Primers , Hydroxymethylglutaryl CoA Reductases/genetics , Lipids/blood , Liver/drug effects , Liver/physiology , Male , Polymerase Chain Reaction , RNA/genetics , RNA, Messenger/genetics , Rats , Rats, Sprague-Dawley , Receptors, LDL/genetics , Sterol Regulatory Element Binding Protein 1/genetics , Triglycerides/blood
SELECTION OF CITATIONS
SEARCH DETAIL
...